Skip to main content
Premium Trial:

Request an Annual Quote

National Academies Panel Gives Nod to Continued Open Access to Pathogen Genomic Data

NEW YORK, Sept. 9 (GenomeWeb News) – A blue-ribbon panel today released a report that recommends no changes in policies that give unrestricted public access to genomic data on microbial pathogens, but said an advisory board should be created to review security implications as genome research continues.

In a report embargoed until this afternoon, a committee organized by the National Academies’ National Research Council and charged with reporting on how biological scientists view policies governing access, said that open access to such data is essential.

“The current vitality of the life sciences depends on a free flow of data and ideas, which is necessary if science is to deliver new biodefense capabilities and improve our ability to fight infectious disease,” the committee chairman, Stanley Falkow, professor of microbiology and immunology at Stanford University, said in a statement.

Completed genomic sequences of more than 100 microbial pathogens -- including smallpox, anthrax, and Ebola hemorrhagic fever – are publicly available in Internet-accessible databases and any genomic data produced using US federal funding are required to be made public.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.